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knowledge about CD1 proteins, their structures, lipid-bind-
ing profiles, and roles in immunity, and evaluate the role of 
CD1 proteins in eliciting humoral immune response.
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Introduction
Major histocompatibility complex (MHC) proteins play an 
essential role in gnathostome immune system by present-
ing antigens to T cells. The mainstream part of that mecha-
nism involves presentation of peptide antigens in two pos-
sible ways depending on their origin. Proteins derived from 
phagocytosed pathogens (e.g., from bacteria or fungi) are 
degraded in the lysosomes: the remnant peptides may be 
captured by the MHC Class II proteins and trafficked to the 
cell surface to engage helper T cells. Endogenous proteins, 
both self and foreign, e.g., viral or derived from intracellu-
lar bacteria, undergo degradation in proteasomes, in which 
case the resulting peptides are carried to the cell surface by 
MHC Class I. The displayed fragments are then probed by 
cytotoxic T cells (Neefjes and Ovaa 2013).
However, self-versus-foreign discrimination is not 
limited to processing and presentation of proteins, but 
involves lipids as well. Lipid antigens are presented by a 
distinct family of MHC Class I-like proteins, named CD1 
(Table 1). Humans express five isoforms of CD1 (CD1a-
CD1e), in contrast to muroids, which express only CD1d 
isotype (Barral and Brenner 2007), and ruminants, which 
express all but CD1c (Van Rhijn et al. 2006). CD1d was 
previously reported to be missing in ruminants too (Van 
Rhijn et  al. 2006; Looringh van Beeck et  al. 2009), but 
recently, it has been shown that the bovine CD1D gene 
Abstract Contrary to general view that the MHC Class I 
and II are the kapellmeisters of recognition and response to 
antigens, there is another big player in that part of immu-
nity, represented by CD1 glycoproteins. In contrast to 
MHC Class I or II, which present peptides, CD1 molecules 
present lipids. Humans express five CD1 proteins (CD1a-
e), four of which (CD1a-d) are trafficked to the cell surface, 
where they may display lipid antigens to T-cell receptors. 
This interaction may lead to both non-cognate and cognate 
T cell help to B cells, the latter eliciting anti-lipid antibody 
response. All CD1 proteins can bind a broad range of struc-
turally different exogenous and endogenous lipids, but each 
shows a preference to one or more lipid classes. This unor-
thodox binding behavior is the result of elaborate architec-
tures of CD1 binding clefts and distinct intracellular traf-
ficking routes. Together, these features make CD1 system 
a versatile player in immune response, sitting at the cross-
roads of innate and adaptive immunity. While CD1 system 
may be involved in numerous infectious, inflammatory, and 
autoimmune diseases, its involvement may lead to oppo-
site outcomes depending on different pathologies. Despite 
these ambiguities and complexity, CD1 system draws 
growing attention and continues to show glimmers of thera-
peutic potential. In this review, we summarize the current 
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is expressed and the protein structure has been solved 
(Nguyen et  al. 2013; Wang et  al. 2012). Two chicken 
CD1 genes identified so far do not match to any of the 
mammalian isoforms, and are, therefore, named CD1.1 
and CD1.2 (Miller et al. 2005; Salomonsen et al. 2005). 
Based on the amino-acid sequence, mammalian CD1 
proteins have been classified into three groups: CD1a-c 
belong to group 1 and present lipid antigens to clonally 
diverse T cells that mediate adaptive immunity, while 
CD1d proteins make up group 2 and present antigens to 
natural killer T cells (NKT) (Cerundolo et  al. 2009). A 
subset of these cells expresses an invariant T-cell recep-
tor (TCR) α-chain and is, therefore, called invariant NKT 
cells (iNKT) (Salio et  al. 2014). Group 3 includes only 
CD1e, which in contrast to CD1a-d is not expressed on 
the cell surface, but serves as a soluble lipid transfer pro-
tein in the endolysosomal network. Thus, some authors 
skip it altogether when writing about CD1 as an antigen 
presentation system (Ly and Moody 2014).
Studies on CD1 system in general, and CD1d-iNKT 
aspect in particular, have been plagued by puzzling and 
sometimes conflicting reports. Sitting at the crossroads 
of innate and adaptive immunity, CD1 system contains 
attractive therapeutic targets, but its complexity and 
ambiguous roles delay its flourish. Yet, as our under-
standing of the system improves, it continues to show 
glimmers of therapeutic potential.
In this review, we summarize the current knowledge 
about CD1 proteins, their structures, lipid-binding pro-
files, and roles in immunity, and we attempt to evaluate 
the role of CD1 proteins in eliciting humoral immune 
response.
Exogenous Lipids Presented by CD1 Molecules
The ability of CD1 molecules to recognize lipid antigens 
and present them to specialized subsets of T cells was dis-
covered by studying the immune response to Mycobacte-
rium tuberculosis antigens (Beckman et al. 1994). The first 
described lipid antigens recognized by CD1 system were 
α-branched and β-hydroxylated long chain fatty acids called 
mycolic acids, presented by CD1b (Porcelli et  al. 1992). 
Many more microbial species that engage CD1 system have 
been identified, including Sphingomonas, Borrelia, pro-
teobacteria, fungi and protozoa such as Leishmania (Tsuji 
2006) (Table 2). CD1 isoforms show different and in some 
cases overlapping binding profiles, which are related to the 
architecture of their binding grooves (de Jong et al. 2007) 
and different trafficking routes through subcellular compart-
ments, causing each isoform to encounter a different set of 
lipid species en route to the cell surface (Lawton and Kro-
nenberg 2004) (Fig. 1). CD1a and (to a lesser extent) CD1c 
predominantly follow early endosomal pathways and recy-
cle to the cell surface, while CD1b and CD1d efficiently 
proceed to late endosomes and lysosomes before resurfac-
ing (Salamero et al. 2001; Van Rhijn et al. 2009). This dif-
ference may hint at how rodents could afford deleting their 
group 1 CD1 and partially explain the capacity of CD1d 
to compensate for the loss (Dascher and Brenner 2003). 
All CD1 molecules are heavily glycosylated type I inte-
gral membrane proteins, and each comprises extracellular 
α1 and α2 domains (which bind antigens), and α3 domain, 
located closer to the membrane and non-covalently associ-
ated with the light chain of β-microglobulin. α3 domain and 
β-microglobulin are both members of the immunoglobulin 
Table 1  Contrasting features of MHC Class I, MHC Class II, and CD1 antigen presentation systems
Feature MHC Class I MHC Class II CD1
Recognized ligands Peptides Peptides Lipids
Ligand processing Peptides derived from 
proteasomal degradation of 
proteins
Peptides derived from lysosomal 
degradation of proteins
Usually not required
Ligand origin Endogenous Exogenous Exogenous or endogenous
Ligand size and shape 8–9 amino acids long peptides 14–20 amino acids long peptides Different lipid types of varying shapes and sizes
Binding site structure Closed-ended groove Open-ended groove Larger clefts of varying shapes and sizes, from 
dead-end single-pass tunnels to riddled maze-
like structures
Expression Most cell types Antigen-presenting cells CD1a-c mostly in antigen-presenting cells, CD1d 
more widely
Degree of polymorphism Highly polymorphic Highly polymorphic Non-polymorphic
Degree of polygenicity Highly polygenic Highly polygenic Non-polygenic (in humans)
Responding T cells CD8+ CD4+ αβ, γδ,  CD4+,  CD8+ or double-negative 
 (CD4−CD8−), iNKT, NKT type II
Arch. Immunol. Ther. Exp. 
1 3
Table 2  Exogenous and endogenous lipid antigens presented by CD1 molecules
Source Lipid antigen CD1 isoform References
Mycobacterium tuberculosis Didehydroxymycobactins CD1a Moody et al. 2004
M. tuberculosis
Mycobacterium spp
Mycolic acids CD1b Beckman et al. 1994
M. tuberculosis
Nocardia farcinica




Glycerol monomycolate CD1b Layre et al. 2009
M. tuberculosis Sulfoglycolipid
Diacylated sulfoglycolipids




Lipoarabinomannan CD1b Sieling et al. 1995
M. tuberculosis Phosphatidylinnositol mannosides CD1b
CD1d























CD1d Kinjo et al. 2005
Mattner et al. 2005







CD1d Kinjo et al. 2006
Kinjo et al. 2011
Helicobacter pylori Glucosyl cholesterol CD1d Chang et al. 2011
Ito et al. 2013
Aspergillus fumigatus Asperamide B
β-linked glucosylceramide





CD1d Amprey et al. 2004
Lotter et al. 2009
Agelas mauritianus α-Galactosylceramide CD1d Kawano et al. 1997
Zajonc et al. 2005a
Koch et al. 2005
Cupressus sempervirens Phosphatidylcholine and phosphatidylethanolamine (18:2/18:2) CD1a Agea et al. 2005
Toxicodendron spp Urushiol CD1a Kim et al. 2016




CD1a de Jong et al. 2010
de Jong et al. 2014
Sulfatide CD1a, b, c
CD1d
Zajonc et al. 2003 
Shamshiev et al. 2002
Bai et al. 2012
Isoglobotriaosylceramide (iGb3) CD1d Zhou et al. 2004b
GM1 ganglioside CD1b Shamshiev et al. 2000
GQ1b ganglioside CD1b Ishida et al. 1994
GD3 ganglioside CD1d Wu et al. 2003
Mannosyl β-1-phosphodolichol CD1c Moody et al. 2000
Phospholipids and lysophospholipids
Phosphatidic acid, phosphatidylinositol, phosphatidylethanola-
mine, phosphatidylcholine, phosphatidylglycerol, phosphatidyl-
serine
CD1b, d Gadola et al. 2002
Cox et al. 2009
Fox et al. 2009
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superfamily (Pei et  al. 2012). CD1 molecules are struc-
turally similar to MHC Class I proteins, but their binding 
grooves are larger and lined with hydrophobic amino-acid 
residues, which reflects the specialization to bind lipids. 
While anchoring within the CD1 proteins, the hydrophobic 
parts of antigens are buried deep inside the groove, while 
the hydrophilic moieties (e.g., carbohydrates and peptides), 
if present, extend out, and are thus exposed to TCRs. Most 
of the data on interactions of TCR with lipid antigens come 
from the studies on CD1d-restricted iNKT cells. Similarly 
to MHC-restricted T-cell response, CD1-restricted T-cell 
response requires recognition of the CD1-ligand complex 
by the TCR, and that contacts be made between the TCR 
binding site and both the CD1 molecule and the hydrophilic 
head of the lipid ligand (Borg et  al. 2007; De Libero and 
Mori 2010a; Van Rhijn et al. 2013). One notable exception 
is activation of CD1a-restricted T cells by CD1a complexes 
with head-less hydrophobic lipids found in the sebum, in 
which case only the contact of the TCR with CD1a triggers 
the T cells (further discussed in the chapter “Endogenous 
lipids presented by CD1 molecules”) (de Jong et al. 2014). 
The strength of T-cell activation depends on the kinetics 
of TCR and CD1-ligand complex binding. Complexes that 
show the highest affinity to TCRs are the strongest agonists 
(Cantu et al. 2003; De Libero and Mori 2010a; McCarthy 
et al. 2007). All CD1 proteins contain binding pockets A′ 
and F′, so named after analogously located MHC Class 
I A and F pockets (Fig.  1). CD1b has the largest binding 
groove (2200 Å3), followed by CD1c (1780 Å3) and CD1d 
(1650 Å3), with CD1a groove being the smallest (1350 Å3) 
(Dellabona et al. 2015). CD1b also reveals two additional 
pockets: C′, corresponding to the C pocket in MHC I, and 
T′, which stands for the “tunnel” that connects A′ and F′ 
pockets (Ly and Moody 2014).
CD1a
CD1a is expressed on thymocytes and antigen-presenting 
cells, predominantly on epidermal Langerhans cells (Dou-
gan et al. 2007). The small cleft of CD1a also reveals the 
simplest structure in comparison with all the other iso-
forms, limiting the size of bound lipids. Because of a 
clearly delineated path through the interior of the mole-
cule, which abruptly terminates in the A′ pocket, CD1a has 
Table 2  (continued)










Methyllysophosphatidic acids (leukemia cells) CD1c Lepore et al. 2014
Fig. 1  CD1 isoforms show 
different architectures of their 
binding clefts, which determine 
their lipid-binding repertoire. 
Although each isoform reveals 
specific binding profile, many 
(mostly endogenous) lipids 
can be presented by all CD1 
molecules. CD1b utilizes 
diacylglycerols (DAGs) and 
deoxyceramides (DOCs) as 
scaffold lipids when presenting 
small exogenous lipids, so they 
are depicted at the interface 
between shared and CD1b 
unique lipid repertoire  
(adapted from Adams 2014)
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been described as a molecular ruler selecting alkyl chains 
of a defined length (Zajonc et  al. 2003). The first identi-
fied exogenous lipids presented by CD1a were dideoxy-
mycobactin lipopeptides, which belong to the mycobacte-
rial siderophores family. Dideoxymycobactin antigens are 
composed of a single N-acyl chain, which fits in CD1a A′ 
pocket, and a complex peptide head group accommodated 
by F′ pocket (Fig. 1) (Moody et al. 2004; Rosat et al. 1999; 
Young et  al. 2009; Zajonc et  al. 2005b). Phosphatidyl-
choline and phosphatidylethanolamine that contain only 
linoleic acids (18:2/18:2), found in cypress pollen, were 
shown to stimulate proliferation of CD1a-restricted T cells 
from cypress allergic subjects (Agea et  al. 2005). Since 
phospholipids and glycolipids make up over 50% of pollen 
grain membranes, and CD1a is frequently overexpressed in 
pulmonary dendritic cells and bronchoalveolar lavage sus-
pensions from allergic individuals, it is suspected that these 
compounds play an important role in the pathogenesis of 
pollen allergy (Russano et al. 2008; Spinozzi and Porcelli 
2007). Recently, CD1a has been demonstrated to recog-
nize urushiol, a sap compound found in the plants of the 
genus Toxicodendron, which causes poison-ivy dermatitis, 
an inflammatory skin disease. The malady is triggered by 
interaction of urushiol with CD1a on Langerhans cells and 
driven by CD1a-restricted T cells. Among different urush-
iol isoforms, a pentadecylcatechol with two unsaturations 
(C15:2) turned out to be the dominant immunogen. Upon 
entry into the CD1a cleft, the aromatic catechol head group 
fills the A′ pocket, while the aliphatic tail spans the F′ 
pocket. About 80% of the molecule is buried within CD1a, 
with the remainder left exposed to TCR (Kim et al. 2016).
CD1b
CD1b is expressed on thymocytes and dendritic cells (Del-
labona et  al. 2015). The largest binding groove of CD1b 
is also the most convoluted with its network of intercon-
nected pockets and tunnels, which has been described as a 
maze for alkyl chains (Gadola et al. 2002a). This complex 
organization allows it to accommodate molecules contain-
ing long fatty acids (C70-80), such as mycolic acid and its 
derivatives: glucose monomycolate and glycerol monomy-
colate (Beckman et al. 1994; Gadola et al. 2002a). Shorter 
mycolic acids (C32–54), such as those found in Corynebac-
terium and Nocardia spp., may also be presented by CD1b 
(Huang et  al. 2011), raising a question of how such rela-
tively small compounds remain accessible for the TCR 
rather than collapse inside the CD1b cleft. Presumably, this 
is achieved due to endogenous lipids, which assume the 
role of scaffolds. In the absence of a foreign ligand, spa-
cious CD1b may be stuffed with two or more endogenous 
lipids. Smaller foreign ligands eject the endogenous lipids 
from the top of the cleft and sit on the lipids located deeper 
(usually a diacylglyceride or deoxydihydroceramide), 
which lend the foreign lipids upward support. Large for-
eign lipids, capable of filling the entire CD1b cleft, may 
oust all scaffold lipids (Huang and Moody 2016; Van Rhijn 
et al. 2015). Interestingly, even the largest recognized lipids 
(C80) are loaded into CD1b intact, despite structural stud-
ies suggesting that such lipids are too bulky to fit in the 
cleft. Since lipids, unlike proteins, are not easily trimmed to 
fit the presenting molecule, anchoring of such large ligands 
is probably accomplished due to an additional (accessory) 
C′ portal, which acts as an escape hatch, through which 
oversized alkyl chains are pushed to the outer surface side 
of CD1b (Cheng et al. 2006).
The big groove of CD1b also allows presentation of 
the cell wall polymers synthesized by Mycobacterium, 
Corynebacterium, and Rhodococcus, such as phosphati-
dylinositol mannosides (PIM), lipomannans, and lipoarabi-
nomannans (Fischer et al. 2004; Sieling et al. 1995).
CD1b also presents diacylated sulfoglycolipids 
expressed by M. tuberculosis, which consist of treha-
lose sulfate acylated at position 2 by short-chain fatty 
acids (predominantly C16:0 or C18:0) and at position 3 
by hydroxyphtioceranoic acid, a long (C32) fatty acid 
with multiple methyl branches. Short-chain length and 
extravagant structure of the acyl chains at positions 2 and 
3, respectively, dictate the antigenicity of these sulfogly-
colipids, which fail to productively engage TCR when these 
chains are too long (position 2) or branchless (position 3). 
Correct configuration of chiral carbons in hydroxyphtiocer-
anoic acid is also required to trigger T-cell response (Gui-
ard et  al. 2009). Similar to Nocardia short-chain mycolic 
acids, sulfoglycolipids that are not able to completely fill 
up the binding groove can be associated with scaffold lipids 
(Fig. 2).
CD1c
CD1c is expressed on dendritic cells and Langerhans 
cells (where together with CD1a, it is one of the only 
two expressed isotypes), as well as on subsets of B cells 
(Adams 2013). In contrast to other CD1 isoforms, CD1c 
is riddled with three additional accessory portals: D′, E′, 
and F′ (Huang and Moody 2016; Scharf et  al. 2010). As 
in the case of C′ portal of CD1b, these perforations either 
function as vents for oversized alkyl chains or additional 
points of entry. The A′ pocket in CD1c is larger than in 
other CD1 proteins and contains a large central pole, which 
creates a torque that coils an incoming alkyl chain around 
it (De Libero and Mori 2010b; Huang and Moody 2016). 
CD1c shows remarkable flexibility and may change its 
overall conformation from completely unroofed to shut 
upon binding of a ligand, reminiscent of a venus fly trap 
snapping over its prey (Mansour et al. 2016). CD1c binds 
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mycobacterial phosphodolichols and phosphomycoke-
tides (Brigl and Brenner 2004). Mycoketides are highly 
branched lipids, containing a single alkyl chain; they func-
tion as growth promoters of mycobacteria in host cells (Sir-
akova et al. 2003), and are produced by pathogenic strains 
of Mycobacterium tuberculosis, Mycobacterium avium, 
and Mycobacterium bovis, but not by fast-growing environ-
mental mycobacteria. Studies on synthetic analogs of man-
nosyl phosphomycoketide revealed that the length, methyl 
branching pattern and the stereochemistry of the polyketide 
chain are essential features influencing the T-cell response 
(de Jong et al. 2007). Studies on phosphomycoketide-reac-
tive T-cell clones isolated from peripheral blood mononu-
clear cells with phosphomycoketide-loaded CD1c showed 
that there are three types of reactivity of T cells: with man-
nosyl phosphomycoketide, phosphomycoketide, or both 
(Roy et  al. 2014). It was shown that mycoketide antigens 
are bound in the A′ pocket and  that methyl groups in the 
mycoketide chain (of C30–C34 length) are essential for 
loading into CD1c (Roy et  al. 2014). The F′ pocket in 
CD1c is distinctively open to the solvent and its main role 
seems to be assistance in loading mycoketide chains into 
the A′ pocket. When smaller lipids are anchored, the F′ 
pocket may be filled with spacer lipids, named so to dis-
tinguish them from scaffold lipids, for the lack of upward 
lifting function in this case (De Libero and Mori 2010b). It 
was shown that infection with Borrelia burgdorferi causes 
upregulation of CD1c on myeloid dendritic cells, but the 
ligands are yet to be determined. In silico studies suggest 
that acylated steryl glycosides from B. burgdorferi may be 
loaded into CD1c (Mansour et al. 2016; Yakimchuk et al. 
2011). In addition, CD1c was found to present synthetic 
lipopeptide acylated at N-terminus (Van Rhijn et al. 2009). 
Interestingly, this ability is lost when CD1c is rerouted to 
lysosomes, which underscores the importance of travers-
ing different intracellular compartments by different CD1 
Fig. 2  Schematic representa-
tion of example glycolipids 
recognized by CD1 molecules
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proteins for ability to recognize and present their typical 
ligands (Adams 2013; Van Rhijn et al. 2009).
CD1d
In contrast to CD1 proteins belonging to group 1, CD1d 
is present on many cell types, including dendritic cells, B 
cells, monocytes, macrophages, keratinocytes, and gastro-
intestinal epithelial cells (Brigl and Brenner 2004). In terms 
of structure complexity and binding capacity, CD1d may be 
considered intermediate when compared with other CD1 
molecules. Its binding groove contains clearly defined A′ 
and F′ pocket with no accessory portals (Salio et al. 2014). 
The toroidal A′ pocket of CD1d is closed and allows the 
insertion of alkyl chains with a defined length, while the 
F′ pocket contains a closed roof that makes binding of very 
long lipid chains impossible (De Libero and Mori 2010a).
The first discovered and most extensively studied ligand 
for CD1d is α-galactosylceramide (αGalCer), a glycosphin-
golipid isolated from marine sponge Agelas mauritianus 
(Fig. 2) (Koch et al. 2005; Zajonc et al. 2005a). The F′ and 
A′ pockets of CD1d can perfectly accommodate the C18 
sphingosine chain and C26 acyl chain of αGalCer, respec-
tively. The galactose ring extends out of the groove and is 
thus exposed for interaction with TCR expressed on iNKT 
cells (Tsuji 2006). There are other, structurally similar 
glycosphingolipids, that are presented by CD1d, such as 
αGalCer from Bacteroides fragilis (a commensal of human 
and mouse gut microbiota), α-glucuronosylceramide from 
Sphingomonas capsulata, α-galacturonosylceramide from 
Sphingomonas yanoikuyae and Sphingomonas wittichii, 
α-galactosyldiacylglycerol from B. burgdorferii, and gly-
cosylated diacylglycerols from Streptococcus pneumoniae 
(Ben-Menachem et al. 2003; Kinjo et al. 2006, 2011; Tsuji 
2006; Wieland Brown et al. 2013).
Similar to CD1b, the CD1d also binds PIM, a lipid syn-
thesized by mycobacteria (Fischer et  al. 2004). Natural 
PIMs derived from Mycobacteria may contain one to six 
mannose residues linked to acylated phosphatidylinositol. 
The PIM found in M. bovis contains four mannose resi-
dues and is, therefore, called PIM4 (Fischer et  al. 2004). 
CD1d was also found to recognize phospholipids from 
Corynebacterium glutamicum or M. tuberculosis, including 
phosphatidylglycerol, diphosphatidylglycerol (cardiolipin), 
and phosphatidylinositol (Fischer et al. 2004; Tatituri et al. 
2013). All were shown to stimulate type II NKT cells, but 
not iNKT cells, and thereby trigger antigen-specific inter-
feron (IFN)-γ production and cell-mediated cytotoxic-
ity. In addition, diphosphatidylglycerol of both bacterial 
and mammalian origin was shown to stimulate γδ T cells, 
which in response secrete IFN-γ and RANTES, and could 
thus function as sentinels during infection and tissue injury 
(Dieudé et al. 2011).
CD1d was also shown to recognize α-galactosyl dia-
cylglycerolipids found in B. burgdorferii and S. pneumo-
niae, the causative agents of Lyme disease and pneumonia, 
respectively (Kinjo et  al. 2011). It was demonstrated that 
iNKT cells are activated in  vivo during an infection with 
B. burgdorferii; this step was shown to be crucial for the 
prevention of chronic joint inflammation and spirochete 
clearance (Tupin et al. 2008). Small changes in length and 
saturation of alkyl chains strongly influence the antigenic 
potency of the lipids (Kinjo et al. 2006). Similarly, recogni-
tion of antigens from S. pneumoniae was shown to rely on 
the presence of 18:1 vaccenic acid linked to sn-2 carbon in 
glycerol residue and on the position of a single unsaturation 
(Kinjo et  al. 2011). Thus, it seems that the requirements 
which the ligands must fulfill to be recognized by CD1d 
go beyond the anomeric configuration of the sugar and are 
quite stringent.
Glycolipids structurally related to cholesterol, 
derived from Helicobacter pylori, such as cholesteryl 
6-tetradecanoyl-α-glucoside, were also identified as NKT 
cell stimulants (Chang et al. 2011).
Although the majority of exogenous lipids recognized 
by CD1d are derived from bacteria, there are also known 
CD1d-presented antigens of protozoan and fungal origin. 
Protozoan surface glycoconjugates such as Leishmania 
donovani lipophosphoglycans (Amprey et  al. 2004), and 
Entamoeba histolytica lipopeptidophosphoglycans (Lotter 
et al. 2009) were shown to stimulate iNKT cells and thus 
stifle the development of amebic liver abscess. Asperamide 
B, β-glucosylceramide derived from Aspergillus fumigatus, 
is the first known fungal glycolipid capable of iNKT cell 
activation in a CD1d-dependent manner (Albacker et  al. 
2013).
CD1e
In contrast to CD1a-d, CD1e is a soluble intracellular pro-
tein (Facciotti et  al. 2011; Garcia-Alles et  al. 2011). It is 
expressed only in dendritic cells and resides in late endoso-
mal and lysosomal compartments, where it assists in lipid 
editing and loading onto presenting CD1 molecules. It has 
been found to assist in turning PIM6 from M. tuberculosis 
into PIM2 motif for presentation by CD1b and in trimming 
of carbohydrate moieties of glycolipids (Cala-De Paepe 
et al. 2012).
Endogenous Lipids Presented by CD1 Molecules
Endogenous lipids, such as phospholipids, lysophospho-
lipids, plasmalogenes, sulfatide, or gangliosides, can be 
recognized by different CD1 molecules (Cox et  al. 2009; 
Dellabona et al. 2015). The majority of endogenous lipids 
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can be presented by all CD1 isoforms, but some isoforms 
reveal preference to one or more lipid types (Dellabona 
et al. 2015). One example of such lipids is sulfatide, a sul-
foglycolipid found mainly in the myelin sheath. It is bound 
by all types of CD1 isoforms, but binding of CD1a is the 
most stable (Shamshiev et  al. 2002; Zajonc et  al. 2003). 
Gangliosides, which are glycosphingolipids containing one 
or more sialic acid residues, are also recognized by CD1 
molecules. The most abundant ganglioside in the human 
myelin sheath, GM1 (GM1a,  II3-α-Neu5Ac-Gg4Cer), is 
bound by CD1b (Chester 1997; Shamshiev et al. 2000), and 
so is GQ1b, which is also present in human brain and con-
tains the same sugar root structure as GM1, but four sialic 
acid residues instead of one (Ishida et  al. 1994) (Fig.  2). 
Since CD1b is expressed by cells in areas of demyelination 
in multiple sclerosis, it has been proposed that gangliosides 
and probably other self-lipids derived from myelin debris, 
such as fast-migrating cerebrosides, may be presented by 
astrocytes and microglia, and thus propel a vicious cycle of 
chronic inflammation (Gately et al. 2013; Shamshiev et al. 
1999). Involvement of CD1d-restricted iNKT cells in mul-
tiple sclerosis is more complicated and seems immunoreg-
ulatory rather than exacerbatory (Hogan et al. 2013).
The carbohydrate moiety of most endogenous glycolip-
ids is β-linked to the lipid portion, while exogenous gly-
colipids typically contain α-glycosidic linkage (Cheng et al. 
2011). Indeed, it was long thought that α-glycosylceramides 
are not produced by mammalian cells at all. This convic-
tion prompted a perennial search for the glycolipid self-
antigen responsible for the positive selection of iNKT cells 
(which strongly respond to α-glycosylceramides) in the 
thymus. Several studies explored isoglobotriaosylceramide 
(iGb3) as the selecting self-antigen, but their conflicting 
results failed to provide the conclusive evidence (Facci-
otti et al. 2012; Godfrey et al. 2006; Porubsky et al. 2007, 
2012; Speak et al. 2007; Yu et al. 2011; Zhou et al. 2004a) 
(Fig. 2). The most dubious aspect of these studies was the 
relevance of iGb3 in humans, because the human iGb3 
synthase gene (A3GALT2) is inactive (Christiansen et  al. 
2008; Lawson 2012; Sanderson et  al. 2013). Surprisingly, 
it was later demonstrated that mammalian immune cells 
indeed produce small quantities of α-glycosylceramides, 
contrary to the long-standing notion (Kain et  al. 2014). 
Thus, the important question is: how are these glycolipids 
synthesized? Since there is no obvious glycosyltransferase 
gene candidate, we suggest that α-galactosylceramide in 
humans may be a secondary product of a promiscuous 
enzyme. Examples of such unfaithful glycosyltransferases 
are known (Kaczmarek et  al. 2014, 2016; Suchanowska 
et  al. 2012; Togayachi et  al. 2001; Westman et  al. 2015). 
Typically, in comparison to the main enzyme products, 
such secondary products occur in minute quantities, which 
may be unmeasurable when using classical biochemical 
methods, yet important in biological environment (Kain 
et al. 2014, 2015). Thus, iNKT cell selection is “more than 
meets the eye”, while the elusive self-antigen could arise as 
a result of biological parsimony.
Other endogenous lipids recognized by CD1d include 
phosphatidic acid, phosphatidylinositol, phosphatidyletha-
nolamine, phosphatidylcholine, phosphatidylglycerol and 
phosphatidylserine, and their lyso-derivatives. Plasmalo-
gens and cardiolipins were also shown to be recognized by 
CD1d (Cox et al. 2009).
Interestingly, components of human skin sebum, i.e., 
wax esters, triacylglycerides, free fatty acids, and squalene, 
were identified as CD1a-presented antigens (de Jong et al. 
2010, 2014). These lipids are unusual CD1 ligands, because 
they do not contain a hydrophilic head group, so their 
nature is completely hydrophobic. It has been proposed that 
they nestle deep inside the CD1a groove and induce the 
correct conformation of CD1a for direct interaction with 
the TCR, which may lead to T-cell activation. Recognition 
of these lipids occurs only upon disruption of the skin bar-
rier, and thus alerts the immune system to the danger before 
invasion of microbes ensues. Without such challenge, 
CD1a binds ubiquitous amphipathic non-stimulatory lipids 
(e.g., phospholipids), which need to be replaced by hydro-
phobic head-less lipids for T cell activation (de Jong 2015). 
CD1a was also shown to recognize lipid products of phos-
pholipases secreted by house dust mites, which thus could 
be implicated in atopic dermatitis (Jarrett and Ogg 2016).
Anti‑lipid Antibodies
Anti-lipid antibodies arise in a number of infectious and 
autoimmune diseases, including leprosy, tuberculosis, sys-
temic lupus erythematosus (SLE), or occur naturally. One 
example of such antibodies is the ones that recognize blood 
group antigens, which may be detrimental upon mismatched 
blood transfusion. However, despite these prominent roles, 
little data are available on the mechanism of emergence of 
anti-lipid antibodies (King et  al. 2011; Poole and Daniels 
2007; Wong-Baeza et al. 2016). Most studies on the role of 
CD1 system in immune response focus on CD1d-restricted 
iNKT cells, because these cells represent a relatively clearly 
defined CD1-restricted T-cell subpopulation. Yet, activated 
iNKT cells may rapidly secrete high amounts of both  TH1 
and  TH2-type cytokines, and so regulate and activate a 
myriad of different cell types (macrophages, dendritic cells, 
and B and T cells) (Fig. 3). Thus, iNKT cell activation may 
lead to opposite outcomes, causing amelioration in some 
pathologies, but exacerbating others (Crosby and Kronen-
berg 2016; King et al. 2011; Novak et al. 2013; Salio et al. 
2014; Siegmann et al. 2014). iNKT cells may provide both 
non-cognate (bystander) and cognate T cell help to B cells. 
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The non-cognate help is more prominent, so iNKT ago-
nists (primarily α-galactosylceramide) have been utilized 
as adjuvants (Artiaga et  al. 2016; Cerundolo et  al. 2009; 
Crosby and Kronenberg 2016; Galli et al. 2007; Novak and 
Lehuen 2011). In contrast, cognate help for lipid-specific B 
cells attracted lesser attention. Yet, anti-lipid antibodies of 
IgG and IgM classes have been described (Poole and Dan-
iels 2007; Wong-Baeza et  al. 2016). IgM antibodies may 
arise against glycoglycerolipids of symbiotic lactobacilli in 
inflammatory bowel disease (Iwamori et al. 2011; Paściak 
et al. 2016). Actinobacterial glycoglycerolipids and saccha-
rolipids also show antigenicity (Paściak et al. 2003, 2004, 
2010). A synthetic haptenated α-galactosylceramide was 
shown to induce robust primary IgG antibodies through 
cognate help from iNKT cells to B cells, but the response 
wanes quickly and is not followed by memory development 
or long-lived plasma-cell differentiation (King et al. 2011; 
Leadbetter et  al. 2008) (Fig. 4a). In contrast, non-cognate 
iNKT cell help for protein-reactive B cells leads to mem-
ory and plasma-cell development, and long-lived antibody 
responses (King et al. 2011) (Fig. 4b). Anti-glycolipid anti-
bodies usually recognize epitopes localized on the carbo-
hydrate moieties of glycolipids. Still, because of their lipid 
nature, glycolipids are believed to elicit humoral response 
through CD1d presentation to iNKT cells and their cog-
nate help to B cells. Perplexingly, this may not always 
be the case, because anti-iGb3 and anti-B blood group 
antigen antibodies were shown to arise in  CD4+ T-cell-
dependent, but CD1d and iNKT cell-independent manner 
(Christiansen et  al. 2011); the exact mechanism, though, 
remains obscure. In contrast, invariant TCR-CD1d interac-
tion was shown to be necessary for the emergence of anti-
bodies against A blood group antigen (Tazawa et al. 2013). 
Since glycolipids carrying A and B blood group antigens 
differ only by N-acetamide moiety in the terminal sugar 
residue (N-acetylgalactosamine in A versus galactose in B 
blood group antigen), it is striking that such a small differ-
ence may determine which part of the immune system is 
involved in response.
Many anti-lipid (often anti-glycolipid) antibodies are 
hallmarks of autoimmune diseases, such as type 1 diabetes 
mellitus, multiple sclerosis, autoimmune hemolytic ane-
mias (Ii blood group system-related cold agglutinin disease 
and paroxysmal cold hemoglobinuria), and SLE (Bovin 
et al. 2012; Kaczmarek et al. 2014). Despite the prominent 
role of CD1-restricted cells in general and iNKT cells in 
particular in these pathologies, the link between these cells 
and the emergence of anti-lipid autoantibodies has rarely 
been investigated (Bovin et  al. 2012; Novak and Lehuen 
2011). IgG autoantibodies found in SLE, which recognize 
mainly phospholipid self-antigens, were shown to arise as 
a result of double-negative T-cell help in a CD1c-restricted 
manner (Sieling et  al. 2000). Recently, it has been dem-
onstrated that success or failure of iNKT cells to control 
self-reactive B-cell responses is driven by their interaction 
with neutrophils during inflammation (Hägglöf et al. 2016). 
Since B-cell response prompted by cognate iNKT cell help 
is rapid but transient, it could paradoxically be viewed as an 
Fig. 3  Activated iNKT cells 
may rapidly secrete high 
amounts of both  TH1 and 
 TH2-type cytokines, and so 
regulate and activate many dif-
ferent cell types
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element of innate response to danger, despite the humoral 
component. This is, perhaps, the most vivid example of 
how CD1 presentation system bridges the innate and adap-
tive immune response (Lawson 2012).
Concluding Remarks
CD1 system continues to draw attention despite its com-
plexity and ambiguities. The rapid nature of immune 
response involving CD1 system drives interest to exploit it 
in vaccination strategies, as well as in infection and autoim-
munity control. One feature in particular makes CD1 pro-
teins interesting targets for drug design: in stark contrast 
to highly donor-restricted patterns of MHC–TCR inter-
action, they are non-polymorphic in human populations. 
Thus, CD1–TCR interactions may be described as donor-
unrestricted, which raises the prospect that lipid agonists 
and antagonists of T cells could be developed (Huang and 
Moody 2016; Van Rhijn and Moody 2015). This, however, 
will require a complete characterization of CD1-restricted 
cell subpopulations, CD1 ligand-binding profiles, and thor-
ough understanding of all factors that contribute to the out-
come of CD1-restricted cell stimulation.
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